WASHINGTON (Reuters) - The flu drugs Tamiflu and Relenza may not be worthwhile to treat seasonal influenza in healthy adults, British researchers reported on Friday.
"Recommending the use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most appropriate course of action," wrote Jane Burch of the University of York and colleagues.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!